Skip to content

Pericapsular Nerve Group (PENG) Block Versus Lumbar Erector Spinae Plane Block

Pericapsular Nerve Group (PENG) Block Versus Lumbar Erector Spinae Plane Block as Postoperative Analgesia in Hip Surgeries: A Randomized Controlled Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04899388
Enrollment
69
Registered
2021-05-24
Start date
2021-06-01
Completion date
2022-02-20
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pericapsular Nerve Group Block (PENG Block), Lumbar Erector Spinae Plane Block

Keywords

Lumbar Erector Spinae Plane Block, Pericapsular Nerve Group Block (PENG Block)

Brief summary

assess and compare the efficacy of pericapsular nerve group block wersus lumber erector spinae plane block in reducing postoperative pain within the first 24 hours after hip surgeries.

Detailed description

after being informed about the study and potential risks. All patients giving written consent will be randomized by double blind manner into 3groups each one containing 23 patients ,PENG group (n =23 ): The patients will receive Pericapsular Nerve Group Block (PENG Block) before positioning for spinal anesthesia. ESPS group E (n =23 ): The patients will receive Lumbar Erector Spinae Plane Block before positioning for spinal anesthesia. Control group C(n =23 ): patients received spinal anesthesia without any block.

Interventions

regional anaesthia

regional anaesthia

DRUGFentanyl

intavenous

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

douple

Eligibility

Sex/Gender
ALL
Age
65 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Aged 65 to 75 years old. American Society of anesthesiologists physical status II and III. Body mass index of 25 to 30 kg/m2.

Exclusion criteria

Altered mental status. History of trauma or multiple fractures Uncontrolled hypertension and or diabetes. Coagulopathy. Preexisting advanced kidney, liver, or heart disease. Allergies or contraindications to the study drugs. Chronic use of opioids or corticosteroids.

Design outcomes

Primary

MeasureTime frameDescription
the time to first postoperative rescue analgesia24 hours postoperativethe time to ask for the first postoperative analgesia (morphine) when the patient is reporting NRS ≥ 3

Secondary

MeasureTime frameDescription
onset of sensory blockafter the blockthe time between the end of the injection of local anesthetic (bupivacaine) and the loss of pin prick sensation using a sterile 25G needle in the operating field.
pain intensity30 minutes after the end of surgery ,3,6,12 hours postoperative.using an 11point numeric rating scale (NRS)(11) : 0: no pain,10=worst imaginable pain) 1-3Mild Pain (nagging, annoying, interfering little with activities of daily living (ADLs). 4-6Moderate Pain (interferes significantly with activities of daily living(ADLs) 7-10Severe Pain (disabling; unable to perform ADLs) at rest and during movement (during45-degree passive flexion of the hip with the ipsilateral knee flexed)
Block performance time (min)immediately before surgerytime from placement of ultrasound probe on the patient's skin to the end of local anesthetic injection
adverse effects24 hours postoperativenausea, vomiting ,hypotension ,bradycardia and hematoma
Patient satisfaction24 hours postoperativerelated to block performance, post-operative pain relief was evaluated by an 11- point satisfaction score (0=unsatisfied and 10 = most satisfied), and the score was divided as follows 0-3 (not satisfied), 4-6 (partly satisfied), and 7-10 (highly satisfied).
The total dose of rescue analgesia24 hours postoperativeThe total dose of rescue analgesia

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026